GlobeNewsWire
04 Jun 2026, 02:13 UTC · 2h ago
Celcuity Inc. Announces Pricing of Upsized Public Offering of 0.250% Convertible Senior Notes Due 2032
Search tags
GlobeNewsWire
04 Jun 2026, 02:13 UTC · 2h ago
Search tags
Story key points
3 claims · impact-rated
Celcuity Inc. priced an upsized public offering of $500 million in 0.250% convertible senior notes due 2032. — Upsized offerings indicate strong investor demand for the company's debt/equity hybrid, providing a significant cash runway for a clinical-stage biotech.
+0.40The company intends to use the net proceeds to fully repay all outstanding obligations under its loan agreement with Oxford Finance, LLC. — Replacing high-cost or restrictive bank debt with lower-coupon convertible notes improves the balance sheet and reduces immediate credit risk.
+0.30The convertible notes feature an initial conversion price of approximately $124.53 per share, representing a 40% premium over the last reported sale price. — A high conversion premium suggests management's confidence in future stock price appreciation and delays immediate dilution.
+0.20Ticker attribution
Continue reading
6 related stories
Model heads
The company successfully priced and upsized a $500 million public offering of convertible senior notes to strengthen its balance sheet and fund operations.
No ticker relationship head found.
Early access
News Impact Screener scores every headline against the stocks it moves — before the chart reacts. Join the early-access list and get alerted the moment a story hits your tickers.
Impact vectors
3 dimensions · 9 clusters
Market reaction
10 bid · 10 offered
7h ago
